Coenzyme Q10 for Gulf War Illness: A Replication Study
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age50+
SponsorUniversity of California, San Diego
About this trial
The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf War illness.
Eligibility criteria
Qualifiers
Meets both CDC and Kansas deployment and symptom inclusion criteria.
Does not have a disqualifying condition.
Able to travel to a local Quest facility for study blood draws.
Adequate internet access to allow ZoomPro visit participation and remote survey completion.
Disqualifiers
Participating in another clinical trial.
Still-evolving adverse effects following another medication or health condition, such as covid or fluoroquinolone use.
On Coumadin/ warfarin.
Unable to participate for the required duration of the study.
Trial design
Treatments tested in this trial
- PharmaNord Bio-Quinone Active CoQ10 Gold 100mg
- PharmaNord Placebo
- PharmaNord Bio-Quinone Active CoQ10 Gold 100mg
Treatment groups
192 Participants
are divided into 3 treatment groupsSponsors and collaborators
University of California, San Diego
Lead sponsor
United States Department of Defense
Collaborator
Source ClinicalTrials.gov